Teresa Brophy Bair, Chief Legal Officer at Kura Oncology, Inc. (KURA), sold 2,100 shares at $15.22 ($32K) on 2022-11-17, disclosed to the SEC on 2022-11-18.
Scheduled sale ($32k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KURA | SELL | 2026-05-20 | $21K | — | Filing → |
| KURA | SELL | 2026-01-27 | $95K | — | Filing → |
| KURA | SELL | 2025-11-14 | $197K | — | Filing → |